Puylaert Kevin bought SOPH
April 2, 2026 · Form 4 insider transaction
Puylaert Kevin bought 82,335 shares of SOPHiA GENETICS SA at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
82,335
Price
$0.00
Total value
N/A
InsiderPuylaert Kevin
Role—
CompanySOPHiA GENETICS SA (SOPH)
SecurityShare Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateApril 2, 2026
Filing dateApril 3, 2026
Shares owned after82,335
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The share option vests and becomes exercisable as to 25% of the ordinary shares on April 2, 2027, and then in equal monthly installments through April 2, 2030.